vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and MARTIN MIDSTREAM PARTNERS L.P. (MMLP). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $187.7M, roughly 1.4× MARTIN MIDSTREAM PARTNERS L.P.). MARTIN MIDSTREAM PARTNERS L.P. runs the higher net margin — 1.7% vs 1.4%, a 0.3% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -2.5%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs 0.8%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Martin Midstream Partners L.P. is a U.S.-based midstream energy services provider. It offers storage, transportation, distribution and processing solutions for crude oil, natural gas liquids, refined petroleum products and specialty chemicals, mainly serving customers across North American energy and industrial segments.
ACAD vs MMLP — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $187.7M |
| Net Profit | $3.6M | $3.2M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 4.1% |
| Net Margin | 1.4% | 1.7% |
| Revenue YoY | 9.7% | -2.5% |
| Net Profit YoY | — | -37.1% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $187.7M | ||
| Q4 25 | $284.0M | $174.2M | ||
| Q3 25 | $278.6M | $168.7M | ||
| Q2 25 | $264.6M | $180.7M | ||
| Q1 25 | $244.3M | $192.5M | ||
| Q4 24 | $259.6M | $171.3M | ||
| Q3 24 | $250.4M | $170.9M | ||
| Q2 24 | $242.0M | $184.5M |
| Q1 26 | $3.6M | $3.2M | ||
| Q4 25 | $273.6M | $-2.9M | ||
| Q3 25 | $71.8M | $-8.4M | ||
| Q2 25 | $26.7M | $-2.4M | ||
| Q1 25 | $19.0M | $-1.0M | ||
| Q4 24 | $143.7M | $-8.9M | ||
| Q3 24 | $32.8M | $-3.3M | ||
| Q2 24 | $33.4M | $3.8M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | 57.1% | ||
| Q3 25 | 92.2% | 55.1% | ||
| Q2 25 | 92.2% | 56.5% | ||
| Q1 25 | 91.7% | 53.5% | ||
| Q4 24 | 91.6% | 58.2% | ||
| Q3 24 | 92.5% | 58.5% | ||
| Q2 24 | 92.5% | 58.4% |
| Q1 26 | -1.7% | 4.1% | ||
| Q4 25 | 6.1% | 7.3% | ||
| Q3 25 | 12.8% | 4.1% | ||
| Q2 25 | 12.2% | 8.2% | ||
| Q1 25 | 7.9% | 7.5% | ||
| Q4 24 | 59.1% | 4.0% | ||
| Q3 24 | 12.6% | 7.4% | ||
| Q2 24 | 12.6% | 10.8% |
| Q1 26 | 1.4% | 1.7% | ||
| Q4 25 | 96.3% | -1.7% | ||
| Q3 25 | 25.8% | -5.0% | ||
| Q2 25 | 10.1% | -1.3% | ||
| Q1 25 | 7.8% | -0.5% | ||
| Q4 24 | 55.4% | -5.2% | ||
| Q3 24 | 13.1% | -1.9% | ||
| Q2 24 | 13.8% | 2.0% |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.86 | — | ||
| Q3 24 | $0.20 | — | ||
| Q2 24 | $0.20 | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | — | $-6.0M |
| FCF MarginFCF / Revenue | — | -3.2% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $27.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $22.4M | ||
| Q3 25 | $74.3M | $-1.2M | ||
| Q2 25 | $64.0M | $30.9M | ||
| Q1 25 | $20.3M | $-6.0M | ||
| Q4 24 | $40.4M | $42.2M | ||
| Q3 24 | $63.2M | $-15.8M | ||
| Q2 24 | $25.0M | $11.8M |
| Q1 26 | — | $-6.0M | ||
| Q4 25 | — | $15.6M | ||
| Q3 25 | $73.9M | $-7.9M | ||
| Q2 25 | — | $25.6M | ||
| Q1 25 | — | $-11.9M | ||
| Q4 24 | — | $34.2M | ||
| Q3 24 | $63.2M | $-25.6M | ||
| Q2 24 | — | $-696.0K |
| Q1 26 | — | -3.2% | ||
| Q4 25 | — | 8.9% | ||
| Q3 25 | 26.5% | -4.7% | ||
| Q2 25 | — | 14.2% | ||
| Q1 25 | — | -6.2% | ||
| Q4 24 | — | 20.0% | ||
| Q3 24 | 25.2% | -15.0% | ||
| Q2 24 | — | -0.4% |
| Q1 26 | — | 1.6% | ||
| Q4 25 | — | 3.9% | ||
| Q3 25 | 0.1% | 4.0% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | 0.0% | 5.8% | ||
| Q2 24 | — | 6.8% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 2.40× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | — | ||
| Q2 24 | 0.75× | 3.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
Segment breakdown not available.
MMLP
| Specialty products | $61.6M | 33% |
| Transportation * | $52.8M | 28% |
| Other | $46.5M | 25% |
| Terminalling and storage * | $22.4M | 12% |
| Sulfur services | $4.4M | 2% |
